// App-Quantinova.ai

e20512 : A Randomized Phase II study of Reolysin in Patients with Previously Treated Advanced or Metatstatic Non Small Cell Lung Cancer (NSCLC) receiving Standard Salvage Chemotherapy Canadian Cancer Trials Group IND 211.

Researchers

Presenter

  • Donald Morris

Principal Investigators

  • Mustapha Ali Tehfe

  • Garth Andrew Nicholas

  • John R. Goffin

  • Richard William Gregg

  • Frances A. Shepherd

  • Nevin Murray

  • Rafal Wierzbicki

  • Christopher W. Lee

  • Sara Kuruvilla

  • Bruce Keith

  • A Ahmed

  • Normand Blais

  • Glenwood D. Goss

  • Grzegorz Korpanty

  • Joana Sederias

  • Scott Andrew Laurie

  • Lesley Seymour

  • Penelope Ann Bradbury

Medical Centers

  • Tom Baker Cancer Center, Calgary, AB, Canada

  • Canadian Cancer Trials Group, Queen's University, Kingston, ON, Canada

  • CRCHUM, Montreal, QC, Canada

  • The Ottawa Hospital Research Institute, Ottawa, ON, Canada

  • Juravinski Cancer Centre, Burlington, ON, Canada

  • Cancer Centre Of Southeastern Ontario, Kingston, ON, Canada

  • Princess Margaret Cancer Center, Toronto, ON, Canada

  • Vancouver Cancer Centre, British Columbia Cancer Agency, Vancouver, BC, Canada

  • R. S. MacLaughlin Durham Regional Cancer Centre, Oshawa, ON, Canada

  • BC Cancer Agency, Surrey, BC, Canada

  • London Health Sciences Center, London, ON, Canada

  • BCCA - Abbotsford Centre, Abbotsford, BC, Canada

  • Allan Blair Cancer Ctr, Regina, SK, Canada

  • Hopital Notre-Dame, CHUM, Montreal, QC, Canada

  • Princess Margaret Hospital, Toronto, ON, Canada

  • NCIC Clinical Trials Group, Kingston, ON, Canada

  • Ottawa Hospital Cancer Center, University of Ottawa, Ottawa, ON, Canada

  • Queen's University, Kingston, ON, CA

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Non Small Cell Lung cancer

Biomarkers

  • N/A

Drug/Treatment

  • Pemetrexed

  • Docetaxel

  • Pelareorep

Outcome

  • N/A

Study Design

  • Randomized

  • Double Blind/Blinded

  • Multicenteric

Phase

  • II

Study Id's

  • NCT01708993

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved